-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Tevogen Bio Holdings Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2023 to Q4 2024.
- Tevogen Bio Holdings Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$9.36M, a 366% decline year-over-year.
- Tevogen Bio Holdings Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$53.6M, a 506% decline year-over-year.
- Tevogen Bio Holdings Inc. annual Operating Income (Loss) for 2024 was -$53.6M, a 506% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)